Stat Surgical Supply

04/15/2026

⚠️ Important Update for Healthcare Teams

The FDA has issued an alert for certain vascular sizing catheters due to a risk of breakage during procedures.

Even though it’s not yet a recall, healthcare providers are being advised to:
✔ Stop using affected products
✔ Review and quarantine inventory
✔ Use alternative devices

This highlights how critical device safety is—even for tools used in routine procedures.

https://www.statsurgicalsupply.com/news/fda-early-alert-on-cook-medical-sizing-catheters-signals-a-high-impact-watch-item-for-interventional-supply-chains

The FDA’s April 9, 2026 early alert on certain Cook Medical sizing catheters is not yet a confirmed recall, but it is already significant news for the U.S. medi...

04/13/2026

⚠️ Important Safety Alert for Healthcare Providers

A serious recall has been issued for certain Impella heart pump purge cassettes due to risks that could affect device performance and patient safety.

Hospitals and care teams are being advised to:
✔ Identify and remove affected products
✔ Quarantine inventory immediately
✔ Transition to updated replacement devices

This highlights how critical every component is in life-supporting medical systems.

https://www.statsurgicalsupply.com/news/purge-cassette-recall-abiomed-removes-impella-heart-pump-purge-cassettes

04/09/2026

💊 Big News in Weight-Loss Treatment

The FDA has approved a new daily pill for weight management — offering an alternative to injections.

This new medication could:
✔ Make treatment easier to start
✔ Improve patient adherence
✔ Expand access to more people

As obesity treatment evolves, convenience is becoming just as important as effectiveness.

👉 This could change how millions approach weight-loss care.
https://www.statsurgicalsupply.com/news/lilly-s-foundayo-wins-fda-approval-opening-a-new-oral-front-in-the-u-s-weight-loss-drug-market

Eli Lilly won U.S. approval on April 1, 2026 for its once-daily obesity pill Foundayo (orforglipron), creating a major new competitor in the fast-growing GLP-1 ...

04/06/2026

🔬 New Advances in Surgical Technology

Medtronic has received FDA clearance to expand its Stealth AXiS system into cranial and ENT surgeries.

This technology combines:
✔ Surgical navigation
✔ Robotics
✔ AI-powered imaging

The goal? Helping surgeons perform complex procedures with greater precision.

This move also highlights a growing trend toward multi-purpose surgical platforms that can be used across different specialties.

👉 Learn how this could shape the future of surgery.
https://www.statsurgicalsupply.com/news/medtronic-expands-stealth-axis-into-cranial-and-ent-surgery-with-new-fda-clearances

03/30/2026

⚠️ Important Update for Surgical Teams

A recall affecting robotic surgery stapler reloads is prompting hospitals and surgical centers to review inventory immediately.

The concern involves potential stapling failures, which can lead to serious complications during procedures.

Because these devices are essential in many surgeries, teams must:
✔ Check and quarantine affected products
✔ Confirm alternative supplies
✔ Adjust surgical planning if needed

This highlights how even small components can have a big impact on patient safety and surgical operations.

https://www.statsurgicalsupply.com/news/intuitive-surgical-stapler-reload-recall-forces-immediate-robotic-or-inventory-review

03/26/2026

Big changes are coming to the healthcare landscape.

The proposed Sutter Health and Allina Health combination could create a massive multi-state system focused on expanding ambulatory and outpatient care.

What does that mean?
More surgeries moving out of hospitals and into efficient outpatient settings — changing how care is delivered and how medical supplies are managed.

For healthcare providers and suppliers, this shift is a big deal.

👉 Read the full story to understand what this means for the future of surgical care.

https://www.statsurgicalsupply.com/news/sutter-allina-deal-signals-a-larger-shift-toward-ambulatory-expansion-in-the-u-s-surgical-market

One of the most consequential strategic developments for the U.S. surgical supply chain was the proposed combination of Sutter Health and Allina Health, a trans...

03/24/2026

The FDA has introduced a new adverse event look-up tool linked to AEMS, a new platform aimed at improving how safety reports are accessed and monitored.

This could help healthcare organizations, manufacturers, and researchers identify safety signals more quickly and respond more effectively.

Read the full article here: https://www.statsurgicalsupply.com/news/fda-launches-new-adverse-event-look-up-tool-introducing-aems-as-a-new-unified-safety-monitoring-platform

03/18/2026

The FDA is taking steps to ease certain biosimilar testing requirements, signaling a push toward faster approvals and lower development costs.

This could help more biosimilar products reach the market, increasing competition in high-cost biologic drug categories and potentially improving affordability across the healthcare system.

Read the full article here: https://www.statsurgicalsupply.com/news/fda-moves-to-ease-biosimilar-testing-rules-signaling-faster-approvals-and-lower-development-costs

The U.S. Food and Drug Administration is moving to simplify parts of the biosimilar approval process, a regulatory shift that could lower development costs, spe...

03/16/2026

Philips has announced that the FDA cleared SmartHeart, an AI-powered cardiac MRI planning system designed to make complex heart imaging easier and more consistent.

Cardiac MRI is one of the most advanced tools for evaluating the heart, but it often requires highly specialized setup and operator experience. According to Philips, SmartHeart helps automate the planning process, which could improve workflow, reduce exam complexity, and support broader access to advanced cardiac imaging.

Read the full article here: https://www.statsurgicalsupply.com/news/ai-powered-cardiac-mri-planning-system-receives-fda-clearance-asiming-to-simplify-complex-heart-imaging

03/12/2026

⚠️ Wound Care Recall Alert

The FDA has confirmed a recall affecting certain MediHoney wound products and CVS wound gel manufactured by Integra LifeSciences due to potential sterile barrier issues.

Healthcare providers are advised to:
• Identify and quarantine affected inventory
• Stop using impacted products
• Ensure substitute wound-care supplies are available

For hospitals and wound-care centers, this recall highlights the importance of strong inventory tracking and rapid response to safety alerts.

https://www.statsurgicalsupply.com/news/fda-confirms-integra-medihoney-and-cvs-wound-product-recall-extending-pressure-on-u-s-wound-care-supply-chains

One of the clearest U.S. device-safety stories from the week of March 2 to March 9, 2026 was the FDA’s March 6 classification and posting of a confirmed recall ...

03/09/2026

⚠️ Important Medical Device Recall Notice

Certain Olympus high-flow laparoscopic insufflation units have been recalled following an FDA Class I designation due to a potential risk of excessive pressure delivery during minimally invasive procedures.

For hospitals and ambulatory surgery centers, this means reviewing equipment inventory, removing affected units from service, and ensuring backup insufflation systems are available to maintain surgical scheduling.

Staying informed about device recalls helps protect both patient safety and surgical workflow continuity.

03/04/2026

A new study presented at the American Academy of Orthopaedic Surgeons meeting suggests that prior authorization requirements may delay elective spine surgery without actually reducing healthcare costs.

Researchers found that most initially denied requests were eventually approved, but the appeals process created delays that kept patients waiting longer for needed surgery.

For hospitals and surgical teams, these delays can also disrupt operating room schedules, supply planning, and patient recovery timelines.

Learn what this means for healthcare providers and patients.
https://www.statsurgicalsupply.com/news/study-presented-at-aaos-finds-prior-authorization-delays-elective-spine-surgery-without-reducing-costs

A new study presented at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) reports that prior authorization (PA) requirements for electi...